Literature DB >> 3351908

Sclerosteosis.

P Beighton1.   

Abstract

Entities:  

Mesh:

Year:  1988        PMID: 3351908      PMCID: PMC1015488          DOI: 10.1136/jmg.25.3.200

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


× No keyword cloud information.
  5 in total

1.  Sclerosteosis in South Africa.

Authors:  P Beighton; H Hamersma
Journal:  S Afr Med J       Date:  1979-05-12

2.  The clinical features of sclerosteosis. A review of the manifestations in twenty-five affected individuals.

Authors:  P Beighton; L Durr; H Hamersma
Journal:  Ann Intern Med       Date:  1976-04       Impact factor: 25.391

3.  The syndromic status of sclerosteosis and van Buchem disease.

Authors:  P Beighton; A Barnard; H Hamersma; A van der Wouden
Journal:  Clin Genet       Date:  1984-02       Impact factor: 4.438

4.  Sclerosteosis - an autosomal recessive disorder.

Authors:  P Beighton; J Davidson; L Durr; H Hamersma
Journal:  Clin Genet       Date:  1977-01       Impact factor: 4.438

5.  The radiology of sclerosteosis.

Authors:  P Beighton; B J Cremin; H Hamersma
Journal:  Br J Radiol       Date:  1976-11       Impact factor: 3.039

  5 in total
  22 in total

1.  Osteocyte control of bone formation via sclerostin, a novel BMP antagonist.

Authors:  David G Winkler; May Kung Sutherland; James C Geoghegan; Changpu Yu; Trenton Hayes; John E Skonier; Diana Shpektor; Mechtild Jonas; Brian R Kovacevich; Karen Staehling-Hampton; Mark Appleby; Mary E Brunkow; John A Latham
Journal:  EMBO J       Date:  2003-12-01       Impact factor: 11.598

2.  Characterization of the interaction of sclerostin with the low density lipoprotein receptor-related protein (LRP) family of Wnt co-receptors.

Authors:  Gill Holdsworth; Patrick Slocombe; Carl Doyle; Bernadette Sweeney; Vaclav Veverka; Kelly Le Riche; Richard J Franklin; Joanne Compson; Daniel Brookings; James Turner; Jeffery Kennedy; Rachael Garlish; Jiye Shi; Laura Newnham; David McMillan; Mariusz Muzylak; Mark D Carr; Alistair J Henry; Thomas Ceska; Martyn K Robinson
Journal:  J Biol Chem       Date:  2012-06-13       Impact factor: 5.157

Review 3.  Medical genetics in South Africa.

Authors:  T Jenkins
Journal:  J Med Genet       Date:  1990-12       Impact factor: 6.318

Review 4.  A Comprehensive Overview of Skeletal Phenotypes Associated with Alterations in Wnt/β-catenin Signaling in Humans and Mice.

Authors:  Kevin A Maupin; Casey J Droscha; Bart O Williams
Journal:  Bone Res       Date:  2013-03-29       Impact factor: 13.567

Review 5.  International classification of osteochondrodysplasias. The International Working Group on Constitutional Diseases of Bone.

Authors:  J Spranger
Journal:  Eur J Pediatr       Date:  1992-06       Impact factor: 3.183

Review 6.  TGF-β Family Signaling in Connective Tissue and Skeletal Diseases.

Authors:  Elena Gallo MacFarlane; Julia Haupt; Harry C Dietz; Eileen M Shore
Journal:  Cold Spring Harb Perspect Biol       Date:  2017-11-01       Impact factor: 10.005

7.  Localization of the gene for sclerosteosis to the van Buchem disease-gene region on chromosome 17q12-q21.

Authors:  W Balemans; J Van Den Ende; A Freire Paes-Alves; F G Dikkers; P J Willems; F Vanhoenacker; N de Almeida-Melo; C F Alves; C A Stratakis; S C Hill; W Van Hul
Journal:  Am J Hum Genet       Date:  1999-06       Impact factor: 11.025

8.  Anatomical similarity between the Sost-knockout mouse and sclerosteosis in humans.

Authors:  Uwe Y Schwarze; Toni Dobsak; Reinhard Gruber; Fred L Bookstein
Journal:  Anat Rec (Hoboken)       Date:  2019-12-17       Impact factor: 2.064

Review 9.  Osteocyte signaling in bone.

Authors:  Mitchell B Schaffler; Oran D Kennedy
Journal:  Curr Osteoporos Rep       Date:  2012-06       Impact factor: 5.096

10.  Rapidly growing Brtl/+ mouse model of osteogenesis imperfecta improves bone mass and strength with sclerostin antibody treatment.

Authors:  Benjamin P Sinder; Joseph D Salemi; Michael S Ominsky; Michelle S Caird; Joan C Marini; Kenneth M Kozloff
Journal:  Bone       Date:  2014-10-23       Impact factor: 4.398

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.